Caricamento...
Beta blockers and angiotensin converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
Preclinical and epidemiologic evidence supports a possible role for beta-adrenergic blocking drugs (beta-blockers), and angiotensin converting enzyme inhibitors (ACEIs) in promoting survival after breast cancer. However, these drugs are often used concurrently with aspirin, and there is a growing bo...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683855/ https://ncbi.nlm.nih.gov/pubmed/23649190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2553-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|